ISPE, through its members’ expertise in epidemiologic research, can provide guidance and drive innovative solutions to key RWE issues.
View the dedicated webpage featuring ISPE members’ work aimed at addressing the COVID-19 pandemic.
Join us for ICPE All Access and celebrate 35 years of real-world science. Our lineup of expert presenters will bring you the latest developments, insights, and trends for pharmacoepidemiology and therapeutic risk management.
ICPE All Access is a collaborative, vibrant platform for sharing stories and ideas with your peers from around the world.
The protests in the US and other countries in response to George Floyd’s death have again emphasized the longstanding and deeply rooted racism and injustice that ISPE members may face. Globally increasing trends of populism, separatism, and fascism and disregard of science are the broader issues that threaten social equality and public health, including our ability to control COVID-19.
The International Society for Pharmacoepidemiology condemns racism and any other form of discrimination against social groups. Each of us individually and as members of ISPE, a society devoted to improving public health needs to confront these threats with all our abilities. We invite suggestions to firstname.lastname@example.org on how we can advance our reach as an international society to support racial justice, equity, and the firm integration of science in decision-making.
The most recent retractions of two high-profile COVID-19 studies have reemphasized the volatility of the public and scientific acceptance of evidence from real-world data and the use of observational designs to make causal inferences about drug effects. Click here to view the full update.
To ensure transparency and continuous engagement with ISPE members, the task force is planning to issue regular progress newsletters to ISPE members. Each newsletter will highlight the objectives and work of a subgroup. Our inaugural newsletter highlights the RWE Reproducibility and Transparency and Collaboration with ISPOR subgroup.